Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
22,937,308
-
Shares change
-
-983,129
-
Total reported value, excl. options
-
$1,299,681,826
-
Value change
-
-$60,738,349
-
Put/Call ratio
-
370%
-
Number of buys
-
94
-
Number of sells
-
78
-
Price
-
$56.62
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q1 2021
As of 31 Mar 2021 Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) had 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,937,308 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, ALETHEA CAPITAL MANAGEMENT, LLC, ALLIANCEBERNSTEIN L.P., STATE STREET CORP, BAKER BROS. ADVISORS LP, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 181 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.